Alpha Fund Finance’s proprietary data reveals private capital funds most in need of GP financing often find it most challenging to access, writes Edward Beecham, head of origination, Alpha Fund Finance.
Demand for general partner (GP) financing is rising sharply across private markets. Fundraising cycles have lengthened, exits have slowed, and investor expectations around GP alignment have increased materially, with commitment levels that once sat at two to three per cent of fund size now commonly expected to reach five per cent or more. At the same time, GP financing is no longer solely about funding commitments. Managers are increasingly using these facilities to support working capital, bridge delays in fee generation, seed new strategies, and manage succession transitions.
Yet despite growing demand, from the work we do in the space – connecting borrowers to lenders and executing fund finance transactions – it is becoming clear that access to GP financing is not expanding evenly. The managers who need it most are often the least able to get it.
Selective expansion
On the surface, the GP financing market looks buoyant. According to Alpha Match data – our proprietary database tracking more than 500 active fund finance lenders – the number of GP lenders we track has more than doubled since 2024, from 51 to 125. Private credit providers have become increasingly visible, offering longer-dated, more flexible capital, while traditional banks have responded by extending tenors and tailoring structures to retain key relationships.
But a growing lender count does not automatically translate into broad-based access. The critical question is not how many lenders exist, but where they are deploying capital and on what terms.
Free cash flow remains king
Analysis of recent GP financing transactions makes one thing clear: management fees remain the cornerstone of lender underwriting. Because they are contractual and predictable, they attract the most favourable credit assessment. Where fee coverage was strong – at 4x for a recent deal we advised on – underwriting proceeded relatively smoothly. Where coverage fell toward or below the 1x–2x range, execution became significantly more challenging, with facilities being resized, heavily structured, or failing to secure terms altogether.
GP interests are increasingly considered but are rarely sufficient on their own. Advance rates remain conservative – typically capped at around 30 per cent – and lender comfort increases only where GP interests are diversified, combined with demonstrable fee coverage, and backed by credible exit visibility.
Widening perception gap
There is a divergence between what managers and lenders consider bankable collateral. Managers often anchor expectations on the headline value of GP interests or projected carry distributions. Lenders, by contrast, focus on the predictability of free cash flows, the diversification of collateral, and the strength of underlying assumptions.
Emerging managers face disadvantage
For smaller and emerging managers, this dynamic creates a real problem. These firms often face the greatest need for GP financing as they scale, meet rising commitment requirements, and navigate longer fundraising cycles. Yet they are also the least likely to meet lender thresholds due to less free cash flow, shorter track records, and smaller, less diversified platforms.
Our data evidences this clearly. While 71 per cent of lenders indicate willingness to consider first-time funds, that figure drops to just 46 per cent among lenders able to provide smaller ticket facilities of £1-5m – precisely the range where genuinely emerging managers sit. Non-bank lenders are more open than their bank counterparts, but the universe remains narrow.
GP financing is becoming an essential tool for private markets managers. The challenge is ensuring that access to it reflects need, rather than just scale.
This is promoted content published in partnership with Alpha Group.
